Winning Stock Forecast: Celldex Therapeutics (CLDX) Remarkable Return of 130.93% Over 1 Month

CLDX Winning Stock Forecast

Source: pixnio

Celldex Therapeutics, Inc., incorporated on December 9, 1983, is a bio-pharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. The Company is using the technologies to develop targeted immunotherapeutics consisting of protein-based molecules, such as vaccines, antibodies and antibody-drug conjugates that are used to treat specific types of cancer or other diseases. The Company’s lead drug Rintega (also referred to as rindopepimut and CDX-110) is a therapeutic

Read More

Winning Stock Forecast: Fannie Mae (OTCMKTS: FNMA) Returns 113.27% in One Month

FNMA Winning Stock Forecast

Source: Wikimedia

Over the period from 21st December to 21st January FNMA saw a stock rise of 113.27% being the biggest earner from the 52-week low forecast package. The Federal National Mortgage Association (FNMA), commonly known as Fannie Mae, is a United States government-sponsored enterprise (GSE). Fannie Mae makes money partly by borrowing at low rates, and then reinvesting its borrowings into whole mortgage loans and mortgage backed securities. It borrows in the debt markets by selling bonds, and provides liquidity to loan originators by purchasing whole loans

Read More

Winning Stock Forecast: DAN And VAC Returns Up to 30.59% and 22.96% in 14 Days.

Dana Incorporated (NYSE: DAN)

[Image Source: commons.wikimedia.org]

Dana Incorporated announced preliminary 2018 financial results and guidance for 2019. Growth of 13% in sales and 15% in adjusted EBITDA, compared with 2017, due to strong end-market demand, conversion of sales backlog and acquisition synergies. The completion of the acquisition of the Drive Systems Segment of the Oerlikon Group (ODS), expected to close by the end of February of 2019 and the acquisition of SME Group is a good reason to stay long. The company’s electrified product portfolio will expand and will be strengthened by Drive System of

Read More

Winning WLK Stock Forecast: Westlake Chemical Partners Returns 22.53% in 14 Days

 

[Image Source: businesswire.com]

Westlake has seen a sharp rise of its stock in the recent few weeks, as it has received growing attention from investors and traders. As of Q3 2018 Robotti Robert has 5.73% invested in the company. Another 55,056 shares of Westlake Chemical Partners are owned by Contradictory Investment Management. Many more institutional clients hold large sums of stocks. WLK pays a dividend of 7.19%, which is very high compared to the industry average. It pays out 97.7% of its earning to its stockholders. On February 19 WLK is expected to report its quarterly earnings

Read More

Winning Stock Forecast Ligand Pharmaceuticals Inc. (LGND). Returns up to 48.60% in 3 Months

Winning Stock Forecast Ligand Pharmaceuticals Inc. (LGND)

Our Winning Stock Forecast Ligand Pharmaceuticals Inc. (NASDAQ: LGND) is a mid-cap Biotech and Pharma company. The company has many programs of collaboration, in numbers, with 95 different Biotech and Pharmaceuticals companies including Baxter, Novartis, Pfizer and Bristol-Myers Squibb. Thanks to these collaborations, the company could arrive in 2020 to 24 new lines the product. However, shares have decreased about 14.9% since the last Earning report published in the end of September 2018. To confirm this, in mid-September price was $254.79 while the Average Volume for LGND shares was $344,030

Read More

Winning Stock Forecast: Arrowhead Pharmaceuticals (NASDAQ: ARWR) Returns up to 321.18% in 1 Year

Source https://it.depositphotos.com/3798928/stock-photo-tablets-medicines.html

Since the beginning of 2018 Arrowhead Pharmaceuticals showed growth catalysts for this year. First, according to the quarterly report for the period ended December 31, 2017, on September 28, 2016 the Company entered into a collaboration agreement with Amgen Inc. The Company received a worldwide license for ARO-AMG1, an RNAi therapy for an undisclosed genetically validated cardiovascular target, that makes Amgen wholly responsible for clinical development and commercialization of this technology. Moreover, the

Read More

Winning World Indices Forecast: ^VIX, ^S&P 500 Perform As Algorithm Predicted

World Indices Package: Notable Performers in the Long and Short Position Amid Volatility

(ShutterStock)

On November 7th 2018, I Know First's top stock predicting algorithm conducted it's 1-Month World Indices Package Forecast. This particular package, which is offered as one of I Know First’s quantitative investment solutions, includes a daily forecast for a total of 20 indices with bullish and bearish signals. This is divided into the top 10 picks for the long position, and top 10 picks for the short position, which are determined by screening our database daily using our advanced algorithm and selecting those with the highest predictability and signal. The two most noteworthy performers of this particular forecast were ^VIX for the long position, and S&P 500 for the short position. The package itself, had an overall average return of 11.28%, in the long position, providing a premium of 15.72% over the SP500’s return of -4.44%. With regards to the short position, the package had an overall average return of 5.79%, providing investors with a premium of 10.23% over S&P500’s return of -4.44%.
Pages:123456»